Adeza regulatory update

The FDA granted marketing approval for the Sunnyvale, Calif., company's test to detect impending preterm delivery in women with symptoms of preterm labor. The test detects the presence of the fetal fibronectin protein (fFN), a biochemical marker predictive of imminent delivery when found in the vaginal secretions of women reporting symptoms of preterm labor between 24 and 34 completed weeks of pregnancy, Adeza said. ...